Merck (MRK) stock-based compensation was $820M in FY2025 (+8% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$820M
+8%
2024
$761M
+18%
2023
$645M
+19%
2022
$541M
+9%
2021
$498M
+5%
2020
$475M
+14%
2019
$417M
+20%
2018
$348M
+12%
2017
$312M
+4%
2016
$300M
+0%
2015
$299M
+8%
2014
$278M
+1%
2013
$276M
-18%
2012
$335M
-9%
2011
$369M
-28%
2010
$509M
+23%
2009
$415M
+19%
2008
$348M
+5%
2007
$330M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q1 2026
$185M
Q4 2025
$205M
Q3 2025
$204M
Q2 2025
$216M
Q1 2025
$195M
Q4 2024
$187M
Q3 2024
$195M
Q2 2024
$203M
Q1 2024
$176M
Q4 2023
$167M
Q3 2023
$164M
Q2 2023
$169M
Source: MRK on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.